Portrait of

Kuei-Chun "Mark" Wang

Featured mentor, FURI

Assistant Professor, School of Biological and Health Systems Engineering

Kuei-Chun (Mark) Wang, Ph.D., is Assistant Professor of Biomedical Engineering in the School of Biological and Health Systems Engineering (SBHSE) at Arizona State University and is affiliated with the John Shufeldt School of Medicine and Medical Engineering. His research integrates vascular biology, cell mechanics, and nanotechnology to develop biomimetic nanotherapeutic and imaging platforms for cardiovascular and cerebrovascular diseases. Dr. Wang has established a nationally recognized research program supported by the National Institutes of Health, National Science Foundation (NSF), Arizona Biomedical Research Centre, and American Heart Association, and is a recipient of the NSF CAREER Award. His work has been published in leading journals such as Nature, PNAS, Circulation, and Biomaterials. In addition to his research, he is committed to mentoring trainees at all levels and advancing biomedical engineering education through curriculum development and interdisciplinary training.

ASU Search

Featured Mentor Q&A

Mark Wang is an assistant professor of biomedical engineering in the School of Biological and Health Systems Engineering. In his Nanotherapeutics & Molecular Engineering Laboratory, Wang uses molecular and cellular bioengineering techniques and biomaterials to develop nano-sized therapeutic and imaging agents that can enhance the diagnosis and treatment of cardiovascular disease. After spending the past four years as a faculty mentor in the FURI and MORE programs, he is eager to encourage more students to participate in these valuable research experiences. Read more

Read more

Spring 2026

Carlos Ignacio Castillo Bock

Biomedical engineering

Developing Blood Vessel-on-a-Chip Platform for Studying Vascular Mechanobiology

Blood vessel-on-a-chip enables more realistic, mechanistic investigation of vascular physiology and disease.

Program: FURI

Summer 2025

Michelle Kim

Computer science

Advancing Tools for Magnetic Resonance Image Analysis of Neurovascular Inflammation

Characterizing the accumulation of a novel, targeted MRI contrast agent could improve diagnostic imaging for traumatic brain injuries.

Program: FURI

Spring 2025

Mark Anthony Orlando

Biomedical engineering

Evaluation of a Novel Small Molecule Drug in Vascular Dysfunction

Advancing vascular nanomedicine for improved treatment of cardiovascular disease.

Program: MORE

Fall 2024

Alexander Benshoof Egan

Biomedical engineering

Leveraging Hybrid Cell Membrane Cloaking for Minimizing Nanoparticle Phagocytosis

Developing hybrid membrane-coated nanoparticles to reduce phagocytosis might improve targeted delivery for cardiovascular disease treatment.

Program: FURI

Summer 2024

Alexander Benshoof Egan

Biomedical engineering

Leveraging Hybrid Cell Membrane Cloaking for Minimizing Nanoparticle Phagocytosis

Developing hybrid membrane-coated nanoparticles to reduce phagocytosis might improve targeted delivery for cardiovascular disease treatment.

Program: FURI

Spring 2024

Hanan Alarnous

Biomedical engineering

Development of Biomimetic Nanoparticles for Smooth Muscle Dysfunction

Developing a characterized biomimetic nano drug presents a promising avenue for effective suppression of dysfunctional smooth muscle cells post-intervention.

Program: MORE

Fall 2023

Mark Anthony Orlando

Biomedical engineering

Enhancing Arterial Tissue Digestion Methods for Deeper Insights into Arterial Disease

Isolating vascular cells from adjacent tissue scaffolds will facilitate access to study cellular expressions related to vascular diseases.

Program: FURI

Summer 2023

Mark Anthony Orlando

Biomedical engineering

Enhancing Arterial Tissue Digestion Methods for Deeper Insights into Arterial Disease

Isolating vascular cells from adjacent tissue scaffolds will facilitate access to study cellular expressions related to vascular diseases.

Program: FURI

Spring 2023

Kylie Hartana

Biomedical engineering

Optimization of Monocyte-Mimicking Nanoparticles for Precise Targeting of Endothelial Inflammation

Optimizing nanoparticle formulation can improve its selectivity and effectiveness for targeting inflammation associated with cardiovascular diseases.

Program: FURI

Hanan Alarnous

Biomedical engineering

Optimization of a Targeted MRI Contrast Agent to Enhance Atherosclerosis Imaging

Developing a lesion-targeted MRI contrast agent will improve imaging capabilities for the early detection of atherosclerosis.

Program: FURI

Spring 2022

Michelle M. Mungaray

Biomedical engineering

Development of Biomimetic Nanoparticles for Highly Efficient CRISPR Delivery

Developing a novel cell membrane-enclosed nanocarrier for efficient CRISPR/Cas9 plasmid delivery will facilitate gene editing applications.

Program: MORE

Fall 2021

Chamonix Michaud

Biomedical engineering

Development of CRISPR Interference Constructs to Modulate the Phenotypic Switch of Vascular Smooth Muscle Cells

Developing a CRISPR interference approach to suppress the pathological phenotype of vascular smooth muscle cells will help people with vascular stenosis.

Program: FURI

Summer 2021

Chamonix Michaud

Biomedical engineering

Development of a Genome Editing Tool to Target Modulation Genes In Vascular Smooth Muscle Tissue

Developing a genome engineering approach to fine-tune the transcriptional regulation in vascular smooth muscle cells will help people with vascular stenosis.

Program: FURI

Spring 2021

Michelle M. Mungaray

Biomedical engineering

Development of a Genome Engineering Approach for the Modulation of Vascular Phenotypes

The successful implementation of the CRISPR interference system will allow for the advancement of cardiovascular therapeutics.

Program: FURI